source
- TScan Therapeutics cuts 75% of staff to focus on preclinical solid tumor programsTScan Therapeutics said it will cut about three quarters of its workforce after pausing its hematological and autoimmune programs. The company will shift resources to its preclinical solid tumor p…
- Funding announcements can hint at upcoming biotech hiring opportunitiesFunding announcements serve as early signals that a biotech company may soon expand its workforce, giving job seekers a chance to reach out before roles are formally posted. Alex Benjamin, vice pr…